BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24655067)

  • 1. Novel approaches to lupus drug discovery using stem cell therapy. Role of mesenchymal-stem-cell-secreted factors.
    Figueroa FE; Cuenca Moreno J; La Cava A
    Expert Opin Drug Discov; 2014 May; 9(5):555-66. PubMed ID: 24655067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concise Review: MSC-Derived Exosomes for Cell-Free Therapy.
    Phinney DG; Pittenger MF
    Stem Cells; 2017 Apr; 35(4):851-858. PubMed ID: 28294454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles.
    Katsuda T; Kosaka N; Takeshita F; Ochiya T
    Proteomics; 2013 May; 13(10-11):1637-53. PubMed ID: 23335344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in mesenchymal stem cell immunomodulation: the role of microvesicles.
    Fierabracci A; Del Fattore A; Luciano R; Muraca M; Teti A; Muraca M
    Cell Transplant; 2015; 24(2):133-49. PubMed ID: 24268069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cell transplantation in systemic lupus erythematous, a mesenchymal stem cell disorder.
    Fathollahi A; Gabalou NB; Aslani S
    Lupus; 2018 Jun; 27(7):1053-1064. PubMed ID: 29631514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic and mesenchymal stem cell transplantation for severe and refractory systemic lupus erythematosus.
    Sui W; Hou X; Che W; Chen J; Ou M; Xue W; Dai Y
    Clin Immunol; 2013 Aug; 148(2):186-97. PubMed ID: 23770628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice.
    Gu F; Molano I; Ruiz P; Sun L; Gilkeson GS
    Clin Immunol; 2012 Nov; 145(2):142-52. PubMed ID: 23041504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cell exosomes.
    Lai RC; Yeo RW; Lim SK
    Semin Cell Dev Biol; 2015 Apr; 40():82-8. PubMed ID: 25765629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes.
    Maumus M; Jorgensen C; Noël D
    Biochimie; 2013 Dec; 95(12):2229-34. PubMed ID: 23685070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease.
    Lai RC; Chen TS; Lim SK
    Regen Med; 2011 Jul; 6(4):481-92. PubMed ID: 21749206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
    El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
    Front Immunol; 2021; 12():643170. PubMed ID: 33732263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients.
    Carrion F; Nova E; Ruiz C; Diaz F; Inostroza C; Rojo D; Mönckeberg G; Figueroa FE
    Lupus; 2010 Mar; 19(3):317-22. PubMed ID: 19919974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic techniques for characterisation of mesenchymal stem cell secretome.
    Kupcova Skalnikova H
    Biochimie; 2013 Dec; 95(12):2196-211. PubMed ID: 23880644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of mesenchymal stem cell-derived microvesicles.
    Biancone L; Bruno S; Deregibus MC; Tetta C; Camussi G
    Nephrol Dial Transplant; 2012 Aug; 27(8):3037-42. PubMed ID: 22851627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncovering the secretes of mesenchymal stem cells.
    Lavoie JR; Rosu-Myles M
    Biochimie; 2013 Dec; 95(12):2212-21. PubMed ID: 23810910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus.
    Zhu Y; Feng X
    Stem Cell Res Ther; 2018 May; 9(1):149. PubMed ID: 29793537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of mesenchymal stem cells on systemic lupus erythematosus:a meta-analysis].
    Liu S; Guo YL; Yang JY; Wang W; Xu J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1014-1021. PubMed ID: 30562774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvesicles as Potential Biomarkers for the Identification of Senescence in Human Mesenchymal Stem Cells.
    Lei Q; Liu T; Gao F; Xie H; Sun L; Zhao A; Ren W; Guo H; Zhang L; Wang H; Chen Z; Guo AY; Li Q
    Theranostics; 2017; 7(10):2673-2689. PubMed ID: 28819455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets?
    Millard SM; Fisk NM
    Bioessays; 2013 Mar; 35(3):173-82. PubMed ID: 23184477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.